Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Lung Protection in Thoracic Aorta Surgery
NCT02678728Phase 4Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- Feb 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in thoracic aortic aneurysm (TAA), thoracic aortic dissection (TAD), sponsored by Gangnam Severance Hospital. Started Feb 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
thoracic aortic aneurysm (TAA)thoracic aortic dissection (TAD)
Beyond the preview
Go deeper on NCT02678728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678728.